BTS
IHE icon

BB&T Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History

BB&T Securities’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$479K Buy
10,221
+57
+0.6% +$2.73K ﹤0.01% 1119
2019
Q2 		$510K Sell
10,164
-18,027
-64% -$891K ﹤0.01% 1085
2019
Q1 		$1.45M Sell
28,191
-2,217
-7% -$110K 0.01% 680
2018
Q4 		$1.43M Buy
30,408
+4,515
+17% +$231K 0.02% 625
2018
Q3 		$1.45M Sell
25,893
-4,602
-15% -$251K 0.01% 697
2018
Q2 		$1.54M Buy
30,495
+636
+2% +$31.5K 0.02% 679
2018
Q1 		$1.47M Buy
29,859
+1,746
+6% +$89.6K 0.02% 654
2017
Q4 		$1.45M Buy
28,113
+1,059
+4% +$54.4K 0.02% 627
2017
Q3 		$1.41M Sell
27,054
-1,320
-5% -$67.8K 0.02% 630
2017
Q2 		$1.47M Sell
28,374
-552
-2% -$27.9K 0.02% 602
2017
Q1 		$1.46M Buy
28,926
+20,406
+240% +$1.01M 0.02% 548
2016
Q4 		$424K Hold
8,520
– – 0.01% 891
2016
Q3 		$424K Sell
8,520
-372
-4% -$18.9K 0.01% 891
2016
Q2 		$428K Sell
8,892
-276
-3% -$13.1K 0.01% 854
2016
Q1 		$418K Buy
9,168
+660
+8% +$30.9K 0.01% 829
2015
Q4 		$458K Buy
8,508
+912
+12% +$48K 0.01% 756
2015
Q3 		$374K Buy
7,596
+3,666
+93% +$210K 0.01% 793
2015
Q2 		$229K Buy
3,930
+210
+6% +$12.3K ﹤0.01% 994
2015
Q1 		$214K Buy
+3,720
New +$203K ﹤0.01% 1006

Other funds holding IHE

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RCYC
Richard C. Young & Co Newport, Rhode Island $1.36B AUM 66.41% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCP
Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BB&T Securities's IHE Position: Q3 2019 in Review

BB&T Securities increased its iShares US Pharmaceuticals ETF (IHE) stake by 0.56% in Q3 2019, buying an estimated $2.73K and bringing the position to 10,221 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #1119.

BB&T Securities first reported a position in IHE in Q1 2015 and has held it in 19 quarters since. The position peaked at $1.54M in Q2 2018. 82 funds tracked by Wall St. Rank hold IHE as of Q3 2019.

  • BB&T Securities held 10,221 shares of iShares US Pharmaceuticals ETF worth $479K as of Q3 2019.
  • BB&T Securities bought 57 iShares US Pharmaceuticals ETF shares in Q3 2019, an estimated $2.73K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1119 holding.
  • BB&T Securities first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and has held it in 19 quarters since.
  • BB&T Securities's iShares US Pharmaceuticals ETF position peaked at $1.54M in Q2 2018.
  • 82 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.